Latest News

  • Home
  • Food & Health
  • Inflammation is the fuel that feeds the cancer flame. So how do we fight back?
Inflammation is the fuel that feeds the cancer flame. So how do we fight back?
Monday, September 9, 2019 IST
Inflammation is the fuel that feeds the cancer flame. So how do we fight back?

Inflammation is the body’s first line of defence against insult. Without inflammation, most of us would not make it past the first year of life. This rapid reaction force fights infections, heals wounds and helps our more sophisticated adaptive immune system generate a longer-lasting specific response. But there is a downside to this powerful response; sometimes inflammation fails to resolve. Indeed, chronic and often low-level inflammation underlies many of the diseases of middle and old age: cardiovascular disease, diabetes, arthritis, dementia – and cancer.
 

 
 

If genetic damage is the match that lights the cancer fire, inflammation is the fuel that feeds the flames. There are multiple lines of evidence that support this idea. Some chronic inflammatory diseases increase the risk of developing a cancer – for instance hepatitis, inflammatory bowel disease and pancreatitis. Cancer can also cause inflammation – genetic damage to a cell with malignant potential attracts inflammatory cells that begin to fuel the cancer flames. Cancers are not just masses of malignant cells but complex ‘rogue organs’ where normal cells are recruited and corrupted to help the cancer grow and spread. This rogue organ is known as the tumour microenvironment and is usually abundant in inflammatory cells and molecules.
 
 
As chronic low level inflammation promotes cancer, are anti-inflammatory drugs useful in cancer prevention and treatment? Over the past twenty years or so experiments in many different mouse models of cancer clearly showed that targeting inflammatory cells or molecules could slow down cancer growth and spread, and if this was done in the earliest stages, cancers could be prevented. The latter finding was replicated in clinical trial of people taking aspirin to prevent cardiovascular disease. These trials, carried out on tens of thousands of people over 10 years or more, show that aspirin reduces the development and spread of certain cancers. However, it is not clear if aspirin benefits all people: the risk of stomach bleeding is increased for instance, and there may be no effect in older people (70+). More research is certainly needed to understand the cancer-preventative actions of this oldest of drugs.
 
An exciting discovery
 
Another more recent clinical trial has excited those of us working on cancer and inflammation. A molecule called interleukin-1 beta (we’ll call it IL-1) is one of the major players in human inflammation. Having evidence that IL-1 might contribute to heart disease, Paul Ridker and colleagues in Boston USA treated patients who were at high risk with a drug that blocked IL-1. Their hypothesis was proven: those receiving the IL-1 blocker suffered less heart disease, but, unexpectedly, patients also developed less cancers, especially lung cancer (many of these patients were smokers). We think that this group of patients already had small lung cancers, because of their smoking history, and the IL-1 blockers stopped progression to detectable malignancy. Again, more clinical trials and lab research are needed but this is a promising finding, especially as the IL-1 trial involved 10,000 individuals.
 
At the moment, anti-inflammatory treatments do not seem to work in advanced human cancers, but over the past 10 years or so rapid advances in immunotherapy have taught us that we can harness the power of the more specific and sophisticated adaptive immune system to fight cancer, even when the cancer is in its final and most lethal stages.
 
Treatments that involve the adjustment of the immune system’s response to cancer and/or the use of CAR T cells – modified human immune cells – stimulate killer T immune cells to recognise and destroy malignant cells, sometimes with such long term beneficial effects that the word ‘CURE’ is appropriate. But these exciting responses only happen with some cancers and some patients. This is where cancer and inflammation research may be able to help. Inflammatory immune cells such as macrophages are abundant in cancers and there is increasing evidence that these cells can be highly immune-suppressive. New treatments that combine immunotherapy with anti-inflammatory strategies hold promise for the future.
 
One approach is to target macrophages – a type of blood cell involved in the immune system - just before using treatments that ‘wake up’ the T cells. Another is to ‘re-educate’ the multitude of macrophages that surround malignant cells. Like T cells, macrophages can recognise and kill malignant cells but in the tumour microenvironment their behaviour is radically altered – they have acquired a number of functions that help the malignant cells survive and spread. Now we have experimental treatments that can switch these ‘bad’ cancer-promoting macrophages to ‘good’ cancer-killing macrophages – essentially waking up a dis-functional army of inflammatory immune cells into an effective fighting force.
 
Although we understand a great deal about cancer-related inflammation, there is more to learn, especially about what happens in human cancers. This is the focus of my research. With funding from the European Research Council and Cancer Research UK, my lab has been developing new models of the tumour microenvironment. As I will describe in the Ideas Lab session, I have been using tissue engineering techniques to grow mini-human tumours in the lab. These are made from multiple human cell types, including inflammatory cells, that grow together in a 3D artificial tumour microenvironment. Other models, in mice, carefully reproduce the genetic mutations and location of the human disease.
 
Our aim is to use these models find the best way of reducing the chronic inflammation of cancer so that the undoubted power of the immune system can be unlocked to attack and destroy cancerous cells and their dangerous tumour microenvironment.

 
 
 
 
 

Related Topics

 
 
 

Trending News & Articles

 Article
12 Early Signs Of Lung Cancer To Never Ignore

Lung cancer is usually not noticeable during the early stages. Most people are diagnosed when the disease is at an advanced stage. According to Cancer.org, it is ...

Recently posted . 8K views . 2 min read
 

 Article
11 Surprising Benefits Of Wood Apple Or Bael Fruit

The health benefits of wood apple include [1] relief from constipation, indigestion, peptic ulcer, piles, respiratory problems, diarrhea, and dysentery. It also b...

Recently posted . 5K views . 2 min read
 

 Article
10 Amazing Benefits Of Bael (Kaitha)

Bael, also known as the “Wood Apple”, is a species native to India. The bael tree is considered to be sacred to the Hindus. A famous drink known as sh...

Recently posted . 5K views . 2 min read
 

 Article
These 7 Remedies Can Remove The Milia (Milk Spots) From Your Face

Do you know what milia are? Milia is a skin condition which causes the appearance of small white hard bumps on the skin which usually appear on the face, neck or ch...

Recently posted . 5K views . 2 min read
 

 
 

More in Food & Health

 Article
You could be suffering from eating disorder if you are diabetic

As many as one-third of young women with diabetes may be struggling with a type of eating disease that prompts them to manipulate or omit insulin intake main to exc...

Recently posted. 814 views . 15 min read
 

 Article
10 Best South Indian Breads You Must Try

South Indian breakfast breads are aplenty and varied. Here we have 10 of the best south Indian breads that you just can't miss!

Recently posted. 1K views . 0 min read
 

 Article
Fish Skin Cheaper, Less Painful in Treating Burns than Bandages: Scientist

Using the skin of Tilapia -- a freshwater fish -- on burns could be effective since it is rich in moisture and collagen proteins.  

Recently posted. 853 views . 1 min read
 

 Article
This is How Breastfeeding linked to Being Righty or Lefty

The reason could be because the region of the brain that controls handedness localises to one side of the brain  

Recently posted. 787 views . 0 min read
 

 Article
World Liver Day 2018: All you need to know about liver health

On World Liver Day, take a look at the importance of keeping your liver healthy, and dos and don’ts for making sure your liver functions properly.

Recently posted. 977 views . 1 min read
 

 
 
 

   Prashnavali

  Thought of the Day

Where there is a will, there is a way.
Anonymous

Be the first one to comment on this story

Close
Post Comment
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST


ads
Back To Top